Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Isolated CNS Relapse of ALL (POG 9412)
NCT00002704Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 1996
- Primary completion
- Jun 2004
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 4
01
Overview
A Phase 2 trial of liposomal cytarabine, thiotepa in acute lymphoblastic leukemia (ALL), sponsored by National Cancer Institute. Started Jan 1996; status: completed.
02
Drugs
liposomal cytarabinethiotepa
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00002704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002704.